NanoEntek Company Description

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers.

The company was founded in 1987 and is headquartered in Seoul, South Korea.

NanoEntek, Inc.

Country	South Korea
Founded	1987
Industry	Laboratory Analytical Instruments
Employees	138
CEO	Jin-Hyung Park

Contact Details

Address: 5, Digital-ro 26-gil Seoul, 08389 South Korea
Phone	82 2 6220 7728
Website	nanoentek.com

Stock Details

Ticker Symbol	039860
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	3826

Key Executives

Name	Position
Jin-Hyung Park	Chief Executive Officer